patent/PA-8799401-A1

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PA-8799401-A1

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fe9babe53dfdfcc0f84b3bbc073d21f4
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-222 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-138 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-138
filingDate	2008-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6d3a0f0105389eac36d9f2b3a66997e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57be68231ec4c74a7d2e1bd0f1fcf0ee http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a10556ea194308d04d1c6cb62d0c4f9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e7b3268092a6012243e03cb3fb9b006
publicationDate	2009-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	PA-8799401-A1
titleOfInvention	USE OF A BLOCKING BETA FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF HEMANGIOMS
abstract	THIS INVENTION CONCERNS THE USE OF A BLOCKING BETA FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF HEMANGIOMS, FOR EXAMPLE OF A CHILD HEMANGIOMS. THE BLOCKING BETA CAN BE A NON-SELECTIVE BLOCKING BETA, FOR EXAMPLE PROPANOLOL. THE PRESENT INVENTION PROVIDES AN ALTERNATIVE TO THE KNOWN COMPOUNDS, FOR example, CORTICOIDS, INTERFERON OR VINCRISTINE, WHICH ARE USED GENERALLY FOR THE TREATMENT OF HEMANGIOMS.
priorityDate	2007-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585571 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4946 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554785 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5978

Total number of triples: 31.